6-Methylmorpholine-2-carboxylic acid, 97%, 100mg

6-Methoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one, 98%, 250mg

5-(Chloromethyl)-3-(4-ethylphenyl)-1,2,4-oxadiazole, 95%, 5g

4-((5-Bromopyridin-2-yl)methyl)morpholine, 95.0%, 500mg

2-CHLORO-1-(5-CHLORO-3-FLUOROPYRIDIN-2-YL)ETHANONE, 95.0%, 1g

(R)-2-Amino-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)propanoic acid, 95.0%, 5g

2-Amino-3-bromo-5-fluorobenzonitrile, 98.0%, 1g

4'-(4-methylpiperazinomethyl)-2-thiomethylbenzophenone, 97.0%, 1g

TEMPO, mínimo 98 %, para síntesis, 5 g, envase de vidrio

3-Chloro-6-ethoxypyridine-2-carboxylic acid, 95%, 250mg

2-Amino-n,3-dimethylbutanamide hydrochloride, 95%, 1g

1-(4-Chlorophenyl)-3,5-dimethyl-1H-pyrazole-4-carbonitrile, 95.0%, 500mg

potassium [(propan-2-yloxy)methanethioyl]sulfanide, 98.0%, 25g